---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-041316"
form_type: "8-K"
ticker: "TKNO"
cik: "0001850902"
company_name: "Alpha Teknova, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T19:16:21.145058+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teknova Q2 revenue $11.5M (+26% seq, -1% YoY); cuts 2023 revenue guidance to $37-40M

## Summary
- Q2 revenue $11.5M, up 26% sequentially but down 1% YoY; net loss $7.2M ($0.25/share).
- Clinical Solutions revenue grew 24% YoY to $3.7M; Lab Essentials fell 10% to $7.6M.
- Company reduces 2023 revenue guidance to $37-40M from prior; maintains free cash outflow ~$30M.
- Received certification for new GMP production facility, expanding capacity to $200M.
- Adjusted EBITDA improved to -$2.3M from -$4.9M; non-cash impairment charge of $2.2M.

## SEC filing metadata
- accession: 0000950170-23-041316
- form_type: 8-K
- ticker: TKNO
- cik: 0001850902
- company_name: Alpha Teknova, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850902/000095017023041316/0000950170-23-041316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850902/000095017023041316/tkno-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-041316
- JSON: https://secwatch.observer/filing/0000950170-23-041316.json
- Plain text: https://secwatch.observer/filing/0000950170-23-041316.txt

## Key facts
- Earnings Releases
  Alpha Teknova, Inc. reported the second quarter ended June 30, 2023 results: revenue $11.5 million, EPS negative $0.25 per diluted share. Guidance lowered.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $11.5 million
  - EPS: negative $0.25 per diluted share
  - Guidance: lowered
  - Result: reported results
  source text: to be furnished under Item 2.02 and --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Teknova Reports Second Quarter 2023 Financial Results Second quarter 2023 total revenue was $11.5 million, up 26% sequentially Received certification of new state-of-the-art facility for production of GMP-grade products Company revises 2023 revenue guidance to $37-40 million,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850902/000095017023041316/0000950170-23-041316-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.